Applied Pharmaceutical Toxicology 2018
April 10, 2018
ReachBio is excited to announce we'll be a sponsor for this year's Applied Pharmaceutical Toxicology (APT) Conference in Boston, Massachusettes at the Merck Research Laboratories, May 15th - 17th.
SOT 57th Annual Meeting and ToxExpo
February 28, 2018
ReachBio will be returning to and exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 57th Annual Meeting in San Antonio, Texas. Our booth, #1631, will display a range of....
ReachBio Research Labs Offers New NK (V158+) Cells Optimized for ADCC Assays online
May 09, 2017
ReachBio's COO, Rob Chaney, talks cellPrism® and growth with CEOCFO Magazine
April 24, 2017
Applied Pharmaceutical Toxicology 2017
April 17, 2017
We're excited to announce we'll be exhibiting at this year's Applied Pharmaceutical Toxicology (APT) Conference in San Francisco, California at Genentech in building 35, May 15th - 17th.
SOT 56th Annual Meeting and ToxExpo
February 15, 2017
We’re happy to announce we’ll be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 56th Annual Meeting in Baltimore, Maryland. Our booth, #1616, will display a range of....
ReachBio Research Labs Launches a New Drug Development Platform, cellPrism®
January 31, 2017
SEATTLE, Jan. 31, 2017 /PRNewswire/ -- ReachBio Research Labs (trade name under Reachbio LLC®) has announced the launch of their new drug development platform, cellPrism®. The platform is designed to....
Human PBMCs Available Online
June 20, 2016
World Preclinical Congress 2016
June 01, 2016
Happy New Year from ReachBio Research Labs!
December 31, 2015
It’s been a good year for growth at ReachBio Research Labs! We’ve really enjoyed working with our existing clients, new clients and those who’ve come back with new contract service and/or product....
Thank you for visiting us at ACT 2015!
November 12, 2015
Thank you to everyone who took the time to visit with us at the American College of Toxicology (ACT) 2015 36th Annual Meeting, this week. We had a great time, and look forward to seeing everyone,....
Effects of Compounds on Thrombopoiesis: Beyond the CFU-Mk Colony Assay
September 11, 2014
The CFU-Mk assay is a robust and predictive in vitro assay for evaluating the toxicity of test compounds on megakaryocytic progenitors. However, sometimes compounds can effect overall thrombopoiesis....
Hemotoxicity Testing: Predictive Lineage-Specific In Vitro Assay Services by ReachBio Research Labs
May 12, 2014
If your drug development program has a particular lineage-specific hemotoxicity issue such as neutropenia (myeloid lineage toxicity), acute anemia (erythroid lineage toxicity) or thrombocytopenia....
ReachBio's Posters Presented at SOT 2014 Are Now Available to Download
April 10, 2014
Interested in in vitro assays to assess the risk of cytokine storms? Or in vitro evaluation of compound effects on leukemic progenitors vs normal progenitors? So are we!
February 27, 2014
Hemotoxicity Testing Services - Are you Eligible for Multi-Assay Discounts?
February 15, 2014
Our in vitro hemotoxicity testing services can provide valuable predictive information regarding compound-induced hemotoxicity on specific lineages: myeloid (CFU-GM assays), erythroid (BFU-E assays)....